Condition
Hospital-acquired Infections
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown2
Completed2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06791382RecruitingPrimary
AI-Driven Prediction of Hospital-Acquired Infections With EHR
NCT05547373Not ApplicableUnknownPrimary
Infection Prevention and Control Intervention to Reduce Hospital-acquired Infections
NCT05201560Not ApplicableUnknown
Efficacy and Safety of Butorphanol Tartrate Injection for the Patients With Mechanical Ventilation
NCT03411538CompletedPrimary
Mortality Related to AMR in Patients With Hospital-acquired Infection
NCT00170560CompletedPrimary
Impact of Gender on Patients
Showing all 5 trials